About Quorum Health (NYSE:QHC)
Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. Its general hospital and outpatient healthcare services include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services. Quorum Health Corporation offers its healthcare services through its hospitals and affiliated facilities, including urgent care centers, diagnostic and imaging centers, physician clinics, and surgery centers. The company, through its subsidiary, Quorum Health Resources, LLC, provides management advisory and consulting services to non-affiliated hospitals. As of January 5, 2018, it owned or leased 31 hospitals with an aggregate of approximately 3,000 licensed beds. The company was incorporated in 2015 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
SymbolNYSE:QHC
CUSIPN/A
Phone615-221-1400
Debt
Debt-to-Equity Ratio10.69%
Current Ratio1.62%
Quick Ratio1.47%
Price-To-Earnings
Trailing P/E Ratio-6.87
Forward P/E Ratio-8.67
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.07 billion
Price / Sales0.13
Cash Flow$1.4809 per share
Price / Cash6.03
Book Value$3.74 per share
Price / Book2.39
Profitability
EPS (Most Recent Fiscal Year)($1.30)
Net Income$-114,190,000.00
Net Margins-5.51%
Return on Equity-34.01%
Return on Assets-2.58%
Miscellaneous
Employees13,000
Outstanding Shares30,300,000
Quorum Health (NYSE:QHC) Frequently Asked Questions
What is Quorum Health's stock symbol?
Quorum Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "QHC."
How were Quorum Health's earnings last quarter?
Quorum Health (NYSE:QHC) issued its quarterly earnings results on Thursday, March, 15th. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The company had revenue of $515.10 million for the quarter, compared to analyst estimates of $502.75 million. Quorum Health had a negative net margin of 5.51% and a negative return on equity of 34.01%. Quorum Health's revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($1.02) earnings per share. View Quorum Health's Earnings History.
When is Quorum Health's next earnings date?
What price target have analysts set for QHC?
4 Wall Street analysts have issued twelve-month price objectives for Quorum Health's shares. Their predictions range from $3.00 to $5.00. On average, they anticipate Quorum Health's stock price to reach $3.8750 in the next year. View Analyst Ratings for Quorum Health.
Who are some of Quorum Health's key competitors?
Some companies that are related to Quorum Health include PetIQ (PETQ), Progenics Pharmaceuticals (PGNX), Achillion Pharmaceuticals (ACHN), AC Immune (ACIU), StemlineTherapeutics (STML), Vectura Group (VEC), American Renal Associates (ARA), Clementia Pharmaceuticals (CMTA), BioCryst Pharmaceuticals (BCRX), Viewray (VRAY), SurModics (SRDX), Insys Therapeutics (INSY), MediciNova (MNOV), Zealand Pharma A/S (ZLDPF), ObsEva (OBSV), Medical Facilities (DR), Zealand Pharma (ZEAL) and Community Health Systems (CYH).
Who are Quorum Health's key executives?
Quorum Health's management team includes the folowing people:
- Mr. Thomas D. Miller, Chief Exec. Officer, Pres and Director (Age 60)
- Mr. Michael J. Culotta, Exec. VP & CFO (Age 63)
- Mr. Martin D. Smith, Chief Operating Officer and Exec. VP of Operations (Age 50)
- Dr. Shaheed Koury M.D., Chief Medical Officer and Sr. VP (Age 51)
- Mr. Ray Harold McCard Jr., Sr. VP, Gen. Counsel and Assistant Sec. (Age 56)
Has Quorum Health been receiving favorable news coverage?
News stories about QHC stock have trended somewhat positive on Thursday, according to Accern. The research firm rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Quorum Health earned a news sentiment score of 0.03 on Accern's scale. They also gave media stories about the company an impact score of 45.42 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Quorum Health?
Shares of QHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Quorum Health's stock price today?
One share of QHC stock can currently be purchased for approximately $8.93.
How big of a company is Quorum Health?
Quorum Health has a market capitalization of $274.79 million and generates $2.07 billion in revenue each year. The company earns $-114,190,000.00 in net income (profit) each year or ($1.30) on an earnings per share basis. Quorum Health employs 13,000 workers across the globe.
How can I contact Quorum Health?
Quorum Health's mailing address is 1573 MALLORY LANE, BRENTWOOD TN, 37027. The company can be reached via phone at 615-221-1400 or via email at [email protected]
MarketBeat Community Rating for Quorum Health (QHC)
MarketBeat's community ratings are surveys of what our community members think about Quorum Health and other stocks. Vote "Outperform" if you believe QHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Quorum Health (NYSE:QHC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Quorum Health in the last 12 months. Their average twelve-month price target is $3.8750, suggesting that the stock has a possible downside of 56.61%. The high price target for QHC is $5.00 and the low price target for QHC is $3.00. There are currently 4 hold ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 1.80 | 1.80 | 1.60 |
| Ratings Breakdown: | 0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $3.8750 | $4.00 | $4.00 | $4.00 |
| Price Target Upside: | 56.61% downside | 28.57% downside | 28.57% downside | 25.65% downside |
Quorum Health (NYSE:QHC) Consensus Price Target History
Quorum Health (NYSE:QHC) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
Quorum Health (NYSE:QHC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Quorum Health (NYSE QHC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 86.92%
Quorum Health (NYSE QHC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/13/2017 | Shaheed Koury | SVP | Buy | 10,000 | $4.69 | $46,900.00 | |  |
| 5/25/2017 | Shaheed Koury | SVP | Buy | 8,500 | $3.56 | $30,260.00 | 88,680 | |
| 5/18/2017 | Ray Harold Mccard Jr | SVP | Buy | 4,000 | $2.67 | $10,680.00 | 67,016 | |
| 5/18/2017 | Thomas Daniel Miller | Insider | Buy | 185,000 | $2.85 | $527,250.00 | 814,139 | |
| 8/15/2016 | Michael J Culotta | CFO | Buy | 80,000 | $5.98 | $478,400.00 | 164,747 | |
| 8/15/2016 | Ray Harold Mccard Jr | SVP | Buy | 8,545 | $5.84 | $49,902.80 | 40,798 | |
| 8/15/2016 | Thomas Daniel Miller | Insider | Buy | 48,200 | $5.85 | $281,970.00 | | |
| 8/15/2016 | William S Hussey | Director | Buy | 5,000 | $5.83 | $29,150.00 | 53,809 | |
| 5/31/2016 | Shaheed Koury | SVP | Buy | 8,000 | $13.29 | $106,320.00 | 37,753 | |
| 5/25/2016 | William M Gracey | Director | Buy | 10,000 | $12.45 | $124,500.00 | 20,000 | |
| 5/20/2016 | James T Breedlove | Director | Buy | 20,000 | $11.92 | $238,400.00 | 20,000 | |
| 5/18/2016 | Thomas Daniel Miller | CEO | Buy | 50,000 | $11.42 | $571,000.00 | 354,274 | |
(Data available from 1/1/2013 forward)
Quorum Health (NYSE QHC) News Headlines
| Source: |
|
Quorum Health (NYSE:QHC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Quorum Health (NYSE:QHC) Income Statement, Balance Sheet and Cash Flow Statement
Quorum Health (NYSE QHC) Stock Chart for Thursday, April, 19, 2018
Loading chart…
